{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:45:28Z","timestamp":1791596728731,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Joint Program on Rare Diseases","award":["01GM2002B"],"award-info":[{"award-number":["01GM2002B"]}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["\u201cMOTASYN\u201d (No.12719684)"],"award-info":[{"award-number":["\u201cMOTASYN\u201d (No.12719684)"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Secr\u00e9tariat g\u00e9n\u00e9ral pour l\u2019investissement","award":["Programme d\u2019investissements d\u2019avenir (PIA)"],"award-info":[{"award-number":["Programme d\u2019investissements d\u2019avenir (PIA)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14735-0","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T09:47:22Z","timestamp":1754992042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Morphological profiling reveals neuroprotection via mitochondrial uncoupling in human dopaminergic neurons"],"prefix":"10.1038","volume":"15","author":[{"given":"Vyron","family":"Gorgogietas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Ogier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Barbuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno F. R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Boussaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Wittich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zaliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Pless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejko","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Wilbertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"14735_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","volume":"130","author":"U W\u00fcllner","year":"2023","unstructured":"W\u00fcllner, U. et al. The heterogeneity of Parkinson\u2019s disease. J. Neural Transm. 130, 827\u2013838 (2023).","journal-title":"J. Neural Transm"},{"key":"14735_CR2","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primer. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"14735_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","volume":"25","author":"R Coukos","year":"2024","unstructured":"Coukos, R. & Krainc, D. Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat. Rev. Neurosci. 25, 393\u2013413 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"14735_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mds.26913","volume":"32","author":"AJ Espay","year":"2017","unstructured":"Espay, A. J. et al. Biomarker-driven phenotyping in parkinson\u2019s disease: A translational missing link in disease\u2010modifying clinical trials. Mov. Disord. 32, 319\u2013324 (2017).","journal-title":"Mov. Disord"},{"key":"14735_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00702-017-1707-x","volume":"124","author":"R Kr\u00fcger","year":"2017","unstructured":"Kr\u00fcger, R. et al. Classification of advanced stages of parkinson\u2019s disease: translation into stratified treatments. J. Neural Transm. 124, 1015\u20131027 (2017).","journal-title":"J. Neural Transm"},{"key":"14735_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s10020-021-00281-8","volume":"27","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn, J. & Br\u00fcggemann, N. Genotype-driven therapeutic developments in parkinson\u2019s disease. Mol. Med. 27, 42 (2021).","journal-title":"Mol. Med."},{"key":"14735_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41591-019-0739-1","volume":"26","author":"AH Laperle","year":"2020","unstructured":"Laperle, A. H. et al. iPSC modeling of young-onset parkinson\u2019s disease reveals a molecular signature of disease and novel therapeutic candidates. Nat. Med. 26, 289\u2013299 (2020).","journal-title":"Nat. Med."},{"key":"14735_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.stemcr.2022.09.001","volume":"17","author":"A Vuidel","year":"2022","unstructured":"Vuidel, A. et al. High-content phenotyping of parkinson\u2019s disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification. Stem Cell. Rep. 17, 2349\u20132364 (2022).","journal-title":"Stem Cell. Rep."},{"key":"14735_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s42256-023-00702-9","volume":"5","author":"K D\u2019Sa","year":"2023","unstructured":"D\u2019Sa, K. et al. Prediction of mechanistic subtypes of parkinson\u2019s using patient-derived stem cell models. Nat. Mach. Intell. 5, 933\u2013946 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"14735_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","volume":"45","author":"A Bose","year":"2022","unstructured":"Bose, A., Petsko, G. A. & Studer, L. Induced pluripotent stem cells: a tool for modeling parkinson\u2019s disease. Trends Neurosci. 45, 608\u2013620 (2022).","journal-title":"Trends Neurosci."},{"key":"14735_CR11","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41467-022-28423-4","volume":"13","author":"L Schiff","year":"2022","unstructured":"Schiff, L. et al. Integrating deep learning and unbiased automated high-content screening to identify complex disease signatures in human fibroblasts. Nat. Commun. 13, 1590 (2022).","journal-title":"Nat. Commun."},{"key":"14735_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ajpath.2015.12.001","volume":"186","author":"B Cholerton","year":"2016","unstructured":"Cholerton, B. et al. Precision medicine. Am. J. Pathol. 186, 500\u2013506 (2016).","journal-title":"Am. J. Pathol."},{"key":"14735_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","volume":"13","author":"AJ Espay","year":"2017","unstructured":"Espay, A. J., Brundin, P. & Lang, A. E. Precision medicine for disease modification in Parkinson disease. Nat. Rev. Neurol. 13, 119\u2013126 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"14735_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-pharmtox-010715-103548","volume":"56","author":"KM Haston","year":"2016","unstructured":"Haston, K. M. & Finkbeiner, S. Clinical trials in a dish: the potential of pluripotent stem cells to develop therapies for neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 56, 489\u2013510 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"14735_CR15","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-Synuclein gene identified in families with parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"14735_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger, R. et al. AlaSOPro mutation in the gene encoding \u03b1-synuclein in parkinson\u2019s disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"14735_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. \u03b1-Synuclein locus triplication causes parkinson\u2019s disease. Science 302, 841\u2013841 (2003).","journal-title":"Science"},{"key":"14735_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin, M. C. et al. \u03b1-synuclein locus duplication as a cause of Familial parkinson\u2019s disease. Lancet 364, 1167\u20131169 (2004).","journal-title":"Lancet"},{"key":"14735_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ncomms1453","volume":"2","author":"MJ Devine","year":"2011","unstructured":"Devine, M. J. et al. Parkinson\u2019s disease induced pluripotent stem cells with triplication of the \u03b1-synuclein locus. Nat. Commun. 2, 440 (2011).","journal-title":"Nat. Commun."},{"key":"14735_CR20","doi-asserted-by":"publisher","first-page":"e26159","DOI":"10.1371\/journal.pone.0026159","volume":"6","author":"B Byers","year":"2011","unstructured":"Byers, B. et al. SNCA triplication parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate \u03b1-Synuclein and are susceptible to oxidative stress. PLoS ONE. 6, e26159 (2011).","journal-title":"PLoS ONE"},{"key":"14735_CR21","doi-asserted-by":"publisher","first-page":"fcab223","DOI":"10.1093\/braincomms\/fcab223","volume":"3","author":"NV Mohamed","year":"2021","unstructured":"Mohamed, N. V. et al. Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy. Brain Commun. 3, fcab223 (2021).","journal-title":"Brain Commun."},{"key":"14735_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41419-022-05330-6","volume":"13","author":"A Iannielli","year":"2022","unstructured":"Iannielli, A. et al. Modeling native and seeded synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications. Cell. Death Dis. 13, 881 (2022).","journal-title":"Cell. Death Dis."},{"key":"14735_CR23","doi-asserted-by":"publisher","first-page":"e1994","DOI":"10.1038\/cddis.2015.318","volume":"6","author":"LMA Oliveira","year":"2015","unstructured":"Oliveira, L. M. A. et al. Elevated \u03b1-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in parkinson\u2019s patient-derived induced pluripotent stem cells. Cell. Death Dis. 6, e1994\u2013e1994 (2015).","journal-title":"Cell. Death Dis."},{"key":"14735_CR24","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/hmg\/ddz038","volume":"28","author":"F Zambon","year":"2019","unstructured":"Zambon, F. et al. Cellular \u03b1-synuclein pathology is associated with bioenergetic dysfunction in parkinson\u2019s iPSC-derived dopamine neurons. Hum. Mol. Genet. 28, 2001\u20132013 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"14735_CR25","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1093\/hmg\/ddx331","volume":"26","author":"SM Heman-Ackah","year":"2017","unstructured":"Heman-Ackah, S. M. et al. Alpha-synuclein induces the unfolded protein response in parkinson\u2019s disease SNCA triplication iPSC-derived neurons. Hum. Mol. Genet. 26, 4441\u20134450 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"14735_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in parkinson\u2019s disease. Science 357, 1255\u20131261 (2017).","journal-title":"Science"},{"key":"14735_CR27","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","volume":"27","author":"PR Angelova","year":"2020","unstructured":"Angelova, P. R. et al. Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell. Death Differ. 27, 2781\u20132796 (2020).","journal-title":"Cell. Death Differ."},{"key":"14735_CR28","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1038\/s41467-021-23682-z","volume":"12","author":"B Tanudjojo","year":"2021","unstructured":"Tanudjojo, B. et al. Phenotypic manifestation of \u03b1-synuclein strains derived from parkinson\u2019s disease and multiple system atrophy in human dopaminergic neurons. Nat. Commun. 12, 3817 (2021).","journal-title":"Nat. Commun."},{"key":"14735_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41573-020-00117-w","volume":"20","author":"SN Chandrasekaran","year":"2021","unstructured":"Chandrasekaran, S. N., Ceulemans, H., Boyd, J. D. & Carpenter, A. E. Image-based profiling for drug discovery: due for a machine-learning upgrade? Nat. Rev. Drug Discov. 20, 145\u2013159 (2021).","journal-title":"Nat. Rev. Drug Discov"},{"key":"14735_CR30","unstructured":"Chandrasekaran, S. N. et al. JUMP Cell Painting Dataset: Morphological Impact of 136,000 Chemical and Genetic Perturbations. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.03.23.534023. 10.1101\/2023.03.23.534023 (2023)."},{"key":"14735_CR31","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/nprot.2016.105","volume":"11","author":"MA Bray","year":"2016","unstructured":"Bray, M. A. et al. Cell painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat. Protoc. 11, 1757\u20131774 (2016).","journal-title":"Nat. Protoc."},{"key":"14735_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbrc.2011.04.053","volume":"408","author":"SJ Park","year":"2011","unstructured":"Park, S. J. et al. A receptor tyrosine kinase inhibitor, tyrphostin A9 induces cancer cell death through Drp1 dependent mitochondria fragmentation. Biochem. Biophys. Res. Commun. 408, 465\u2013470 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14735_CR33","doi-asserted-by":"publisher","first-page":"36204","DOI":"10.1074\/jbc.M203895200","volume":"277","author":"Y Sagara","year":"2002","unstructured":"Sagara, Y., Ishige, K., Tsai, C. & Maher, P. Tyrphostins protect neuronal cells from oxidative stress. J. Biol. Chem. 277, 36204\u201336215 (2002).","journal-title":"J. Biol. Chem."},{"key":"14735_CR34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s12035-022-02723-8","volume":"59","author":"AFF Ferreira","year":"2022","unstructured":"Ferreira, A. F. F. et al. Inhibition of TRPM2 by AG490 is neuroprotective in a parkinson\u2019s disease animal model. Mol. Neurobiol. 59, 1543\u20131559 (2022).","journal-title":"Mol. Neurobiol."},{"key":"14735_CR35","doi-asserted-by":"publisher","first-page":"120383","DOI":"10.1016\/j.lfs.2022.120383","volume":"294","author":"X Dai","year":"2022","unstructured":"Dai, X. et al. Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs. Life Sci. 294, 120383 (2022).","journal-title":"Life Sci."},{"key":"14735_CR36","doi-asserted-by":"publisher","first-page":"e0244499","DOI":"10.1371\/journal.pone.0244499","volume":"15","author":"IR Iaubasarova","year":"2020","unstructured":"Iaubasarova, I. R. et al. The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler. PLOS ONE. 15, e0244499 (2020).","journal-title":"PLOS ONE"},{"key":"14735_CR37","doi-asserted-by":"publisher","first-page":"103145","DOI":"10.1016\/j.scr.2023.103145","volume":"71","author":"A Chemla","year":"2023","unstructured":"Chemla, A. et al. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from parkinson\u2019s disease patients carrying the heterozygous mutations c.815G\u2009>\u2009A (p.R272Q) or c.1348C\u2009>\u2009T (p.R450C) in the RHOT1 gene encoding Miro1. Stem Cell. Res. 71, 103145 (2023).","journal-title":"Stem Cell. Res."},{"key":"14735_CR38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/auto.4600","volume":"3","author":"N Mizushima","year":"2007","unstructured":"Mizushima, N. & Yoshimori, T. How to interpret LC3 Immunoblotting. Autophagy 3, 542\u2013545 (2007).","journal-title":"Autophagy"},{"key":"14735_CR39","doi-asserted-by":"publisher","first-page":"fcae101","DOI":"10.1093\/braincomms\/fcae101","volume":"6","author":"AH McDiarmid","year":"2024","unstructured":"McDiarmid, A. H. et al. Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer\u2019s disease. Brain Commun. 6, fcae101 (2024).","journal-title":"Brain Commun."},{"key":"14735_CR40","doi-asserted-by":"publisher","first-page":"eadf3771","DOI":"10.1126\/sciadv.adf3771","volume":"9","author":"X Han","year":"2023","unstructured":"Han, X. et al. Whole human-brain mapping of single cortical neurons for profiling morphological diversity and stereotypy. Sci. Adv. 9, eadf3771 (2023).","journal-title":"Sci. Adv."},{"key":"14735_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-021-03941-1","volume":"598","author":"H Peng","year":"2021","unstructured":"Peng, H. et al. Morphological diversity of single neurons in molecularly defined cell types. Nature 598, 174\u2013181 (2021).","journal-title":"Nature"},{"key":"14735_CR42","doi-asserted-by":"publisher","first-page":"113784","DOI":"10.1016\/j.celrep.2024.113784","volume":"43","author":"P Kilfeather","year":"2024","unstructured":"Kilfeather, P. et al. Single-cell Spatial transcriptomic and Translatomic profiling of dopaminergic neurons in health, aging, and disease. Cell. Rep. 43, 113784 (2024).","journal-title":"Cell. Rep."},{"key":"14735_CR43","doi-asserted-by":"publisher","first-page":"e69795","DOI":"10.7554\/eLife.69795","volume":"10","author":"GHJ Kim","year":"2021","unstructured":"Kim, G. H. J. et al. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. eLife 10, e69795 (2021).","journal-title":"eLife"},{"key":"14735_CR44","doi-asserted-by":"publisher","first-page":"1026468","DOI":"10.3389\/fnagi.2022.1026468","volume":"14","author":"J Cui","year":"2022","unstructured":"Cui, J., Carey, J. & Reijo Pera, R. A. Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival. Front. Aging Neurosci. 14, 1026468 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"14735_CR45","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","volume":"11","author":"Y Tabata","year":"2018","unstructured":"Tabata, Y. et al. T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in Familial Parkinson disease. Stem Cell. Rep. 11, 1171\u20131184 (2018).","journal-title":"Stem Cell. Rep."},{"key":"14735_CR46","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.stemcr.2020.04.011","volume":"14","author":"A Yamaguchi","year":"2020","unstructured":"Yamaguchi, A. et al. Identifying therapeutic agents for amelioration of mitochondrial clearance disorder in neurons of Familial Parkinson disease. Stem Cell. Rep. 14, 1060\u20131075 (2020).","journal-title":"Stem Cell. Rep."},{"key":"14735_CR47","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1038\/s41467-024-50454-2","volume":"15","author":"G Asantewaa","year":"2024","unstructured":"Asantewaa, G. et al. Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression. Nat. Commun. 15, 6152 (2024).","journal-title":"Nat. Commun."},{"key":"14735_CR48","doi-asserted-by":"publisher","first-page":"100169","DOI":"10.1074\/jbc.RA120.016551","volume":"296","author":"F Cvetko","year":"2021","unstructured":"Cvetko, F. et al. Nrf2 is activated by disruption of mitochondrial thiol homeostasis but not by enhanced mitochondrial superoxide production. J. Biol. Chem. 296, 100169 (2021).","journal-title":"J. Biol. Chem."},{"key":"14735_CR49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.freeradbiomed.2008.10.040","volume":"46","author":"CJ Harvey","year":"2009","unstructured":"Harvey, C. J. et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol. Med. 46, 443\u2013453 (2009).","journal-title":"Free Radic Biol. Med."},{"key":"14735_CR50","first-page":"1420","volume":"63","author":"M von Willebrand","year":"2003","unstructured":"von Willebrand, M., Zacksenhaus, E., Cheng, E., Glazer, P. & Halaban, R. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells. Cancer Res. 63, 1420\u20131429 (2003).","journal-title":"Cancer Res."},{"key":"14735_CR51","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1242\/jcs.026005","volume":"121","author":"E Shvets","year":"2008","unstructured":"Shvets, E., Fass, E., Scherz-Shouval, R. & Elazar, Z. The N-terminus and Phe52 residue of LC3 recruit p62\/SQSTM1 into autophagosomes. J. Cell. Sci. 121, 2685\u20132695 (2008).","journal-title":"J. Cell. Sci."},{"key":"14735_CR52","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4161\/auto.7.7.15279","volume":"7","author":"E Shvets","year":"2011","unstructured":"Shvets, E., Abada, A., Weidberg, H. & Elazar, Z. Dissecting the involvement of LC3B and GATE-16 in p62 recruitment into autophagosomes. Autophagy 7, 683\u2013688 (2011).","journal-title":"Autophagy"},{"key":"14735_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4161\/auto.2.2.2405","volume":"2","author":"G Bj\u00f8rk\u00f8y","year":"2006","unstructured":"Bj\u00f8rk\u00f8y, G., Lamark, T. & Johansen, T. p62\/SQSTM1: A missing link between protein aggregates and the autophagy machinery. Autophagy 2, 138\u2013139 (2006).","journal-title":"Autophagy"},{"key":"14735_CR54","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1182\/blood-2004-03-1216","volume":"105","author":"P Walrafen","year":"2005","unstructured":"Walrafen, P. et al. Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105, 600\u2013608 (2005).","journal-title":"Blood"},{"key":"14735_CR55","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0005-2728(75)90089-4","volume":"387","author":"H Terada","year":"1975","unstructured":"Terada, H. & Van Dam, K. On the, stoichiometry between uncouplers of oxidative phosphorylation and respiratory chains. The catalytic action of SF 6847 (3,5-di-tert-butyl-4-hydroxybenzylidenemalononitrile). Biochim. Biophys. Acta BBA - Bioenerg. 387, 507\u2013518 (1975).","journal-title":"Biochim. Biophys. Acta BBA - Bioenerg"},{"key":"14735_CR56","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jalz.2016.08.001","volume":"13","author":"JG Geisler","year":"2017","unstructured":"Geisler, J. G., Marosi, K., Halpern, J. & Mattson, M. P. DNP, mitochondrial uncoupling, and neuroprotection: A little dab\u2019ll do Ya. Alzheimers Dement. 13, 582\u2013591 (2017).","journal-title":"Alzheimers Dement."},{"key":"14735_CR57","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/brainsci11081050","volume":"11","author":"DB Zorov","year":"2021","unstructured":"Zorov, D. B. et al. Neuroprotective potential of mild uncoupling in mitochondria. Pros and cons. Brain Sci. 11, 1050 (2021).","journal-title":"Brain Sci."},{"key":"14735_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0005-2728(88)90070-9","volume":"933","author":"H Terada","year":"1988","unstructured":"Terada, H., Fukui, Y., Shinohara, Y. & Ju-ichi, M. Unique action of a modified weakly acidic uncoupler without an acidic group, methylated SF 6847, as an inhibitor of oxidative phosphorylation with no uncoupling activity: possible identity of uncoupler binding protein. Biochim. Biophys. Acta BBA - Bioenerg. 933, 193\u2013199 (1988).","journal-title":"Biochim. Biophys. Acta BBA - Bioenerg"},{"key":"14735_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti, L. et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628, 195\u2013203 (2024).","journal-title":"Nature"},{"key":"14735_CR60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao, C., Jiang, J., Tan, Y. & Chen, S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal. Transduct. Target. Ther. 8, 359 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"14735_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-023-06713-1","volume":"623","author":"DS Park","year":"2023","unstructured":"Park, D. S. et al. iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer. Nature 623, 397\u2013405 (2023).","journal-title":"Nature"},{"key":"14735_CR62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41380-022-01892-1","volume":"28","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Microglia-containing human brain organoids for the study of brain development and pathology. Mol. Psychiatry. 28, 96\u2013107 (2023).","journal-title":"Mol. Psychiatry"},{"key":"14735_CR63","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.14286","volume":"49","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR \u2010mediated deletion of the SNCA gene. Eur. J. Neurosci. 49, 510\u2013524 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"14735_CR64","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of parkinson\u2019s disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"14735_CR65","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan, S. D. et al. Isogenic human iPSC parkinson\u2019s model shows nitrosative Stress-Induced dysfunction in MEF2-PGC1\u03b1 transcription. Cell 155, 1351\u20131364 (2013).","journal-title":"Cell"},{"key":"14735_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/ejn.14345","volume":"49","author":"B Weykopf","year":"2019","unstructured":"Weykopf, B. et al. Induced pluripotent stem cell-based modeling of mutant LRRK2-associated parkinson\u2019s disease. Eur. J. Neurosci. 49, 561\u2013589 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"14735_CR67","doi-asserted-by":"publisher","unstructured":"McKinney, W. Data structures for statistical computing in python. Proc. 9th Python Sci. Conf. 56-61 https:\/\/doi.org\/10.25080\/Majora-92bf1922-00a (2010).","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"14735_CR68","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. Seaborn: statistical data visualization. J. Open. Source Softw. 6, 3021 (2021).","journal-title":"J. Open. Source Softw."},{"key":"14735_CR69","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14735-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:27:15Z","timestamp":1757381235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14735-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14735"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14735-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.19.613945","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.We., L.C., D.H., K.S., A.O., P.S., and J.H.W. are or were employed by Ksilink. R.K. is receiving or has received research grants from the European Institute of Innovation and Technology (EIT Health), the Innovative Medicines Initiative (IMI) of the European Union and the European pharmaceutical industry, as well as personal speaker\u2019s honoraria and\/or travel grants from Abbvie, Zambon and Medtronic; R.K. participated as PI or site-PI for industry sponsored clinical trials without receiving honoraria. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29507"}}